Advanced search
Publication Cover
Ophthalmic Epidemiology Volume 22, 2015 - Issue 1: Eye Health Economics, Guest Editors: Steven M. Kymes and Kevin Frick
Submit an article Journal homepage
414
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Utility Values Associated with Diabetic Retinopathy in Chennai, India

Sarah PolackInternational Centre for Eye Health and International Centre for Evidence in Disability, Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK and Correspondence[email protected]
,
Yasmene AlaviInternational Centre for Eye Health and International Centre for Evidence in Disability, Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK and
,
Sudhir Rachapalle ReddiDepartment of Preventive Ophthalmology, Sankara Nethralaya, Vision Research Foundation, Chennai Tamil Nadu, India
,
Vaitheeswaran KulothunganDepartment of Preventive Ophthalmology, Sankara Nethralaya, Vision Research Foundation, Chennai Tamil Nadu, India
&
Hannah KuperInternational Centre for Eye Health and International Centre for Evidence in Disability, Clinical Research Department, London School of Hygiene & Tropical Medicine, London, UK and
Pages 20-27 | Received 16 Mar 2012, Accepted 01 Oct 2013, Published online: 26 Mar 2014

References

  • Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047–1053
  • The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthalmology 1981;88:583–600
  • Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology 1991;98:766–785
  • Brown MM, Brown GC, Sharma S, Shah G. Utility values and diabetic retinopathy. Am J Ophthalmol 1999;128:324–330
  • Sharma S, Chen SJ, Lee FL, et al. Utilities associated with diabetic retinopathy: results from a Canadian sample. Br J Ophthalmol 2003;87:259–261
  • Tung TH, Srinivasan G, Mei SS, et al. A community-based study for the utility values associated with diabetic retinopathy among type 2 diabetics in Kinmen, Taiwan. Diabetes Res Clin Pract 2005;68:265–273
  • Gupta V, Brown GC, Sharma S, et al. Utility values among glaucoma patients: an impact on the quality of life. Br J Ophthalmol 2005;89:1241–1244
  • Brown GC, Brown MM, Sharma S, et al. The reproducibility of ophthalmic utility values. Trans Am Ophthalmol Soc 2001;99:199–203; discussion 203–194
  • Jampel HD. Glaucoma patients’ assessment of their visual function and quality of life. Trans Am Ophthalmol Soc 2001;99:301–317
  • Wilkinson CP, Ferris FL, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110:1677–1682
  • Raman R, Rani PK, Reddi Rachepalle S, et al. Prevalence of diabetic retinopathy in India: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study report 2. Ophthalmology 2009;116:311–318
  • Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001;33:337–343
  • Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095–1108
  • Vyas S, Kumaranayake L. Constructing socio-economic status indices: how to use principal components analysis. Health Policy Plan 2006;21:459-468
  • Lamping DL, et al. The community-acquired pneumonia symptom questionnaire: a new, patient-based outcome measure to evaluate symptoms in patients with community-acquired pneumonia. Chest 2002;122:920–929
  • Sakthong P, Charoenvisuthiwongs R, Shabunthom R. A comparison of EQ-5D index scores using the UK, US, and Japan preference weights in a Thai sample with type 2 diabetes. Health Qual Life Outcomes 2008;6:71
  • Kymes SM, Lee BS. Preference-based quality of life measures in people with visual impairment. Optom Vis Sci 2007;84:809–816
  • Johnson JA, Luo N, Shaw JW, et al. Valuations of EQ-5D health states: are the United States and United Kingdom different? Med Care 2005;43:221–228

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.